CBD Market Overview: Europe 2025

The European CBD market continues to operate under a fragmented and inconsistent regulatory landscape, with tolerance levels varying significantly by country. While some governments have adopted progressive frameworks allowing low-THC hemp products across food, cosmetics, and vape segments, others maintain restrictive interpretations under narcotics and novel food laws.

The EU Novel Food Regulation remains the central barrier to the ingestion of CBD products. As of 2025, no CBD product has received full EU authorisation as a novel food, creating widespread legal uncertainty for ingestible products. In contrast, topical and cosmetic formulations—subject to cosmetic safety and labelling laws—are widely tolerated.

Several markets, including Switzerland, Austria, and the Czech Republic, have introduced more liberal domestic regimes, while Italy, Ireland, and Finland continue to enforce strict measures limiting or criminalising CBD products that contain any trace of THC.

Below is a summary of CBD market tolerance levels and regulatory positions across key European countries.

Tolerance: Low CBD food supplements and ingestible oils are regulated by the Food Safety Authority of Ireland (FSAI) and must obtain Novel Food authorisation—none have been approved. Cosmetic CBD products are available, but ingestibles and flowers operate in a grey market. The government maintains active enforcement, with raids and product seizures continuing. In 2024, a High Court challenge seeking approval for non-intoxicating CBD with trace THC was dismissed.

Tolerance: High The UK hosts one of Europe’s largest CBD markets, despite persistent regulatory ambiguity. The Food Standards Agency (FSA) continues reviewing Novel Food applications, with limited progress toward final approvals. Import disruptions persist as the Home Office seizes products containing trace THC, though court challenges from businesses are ongoing.

Tolerance: Low Portugal’s CBD sector remains small and under-regulated. Authorities make no clear distinction between hemp-derived and cannabis-derived CBD. CBD stores operate informally, but are subject to raids and confiscations, including cosmetic removals ordered by health authorities in February 2025.

Tolerance: Medium Spain’s CBD market, particularly in Barcelona, is active but precarious. Authorities continue to crack down on grey-market operators, seizing oils and flowers that exceed unclear THC thresholds. Only cosmetic products are officially recognised as legitimate by regulators.

Tolerance: Medium France’s initial tolerance has been replaced by regulatory caution, with both the ANSM (medicines agency) and ANSES (food authority) citing potential health and fertility risks linked to CBD. In September 2024, France submitted an EU-level proposal to ban CBD based on reproductive toxicity concerns. Despite this, enforcement against domestic CBD sales remains limited.

Tolerance: Medium Since April 2019, Belgium has formally regulated CBD flower cigarettes below 0.2% THC. CBD oils and cosmetics are widely available, though store raids occasionally occur.

Tolerance: High CBD and hemp with up to 1% THC are permitted as tobacco substitutes, taxed and regulated accordingly. CBD cosmetics are legal, though ingestibles remain subject to Novel Food restrictions.

Tolerance: Medium CBD products are legal under 0.05% THC, widely available in retail, pharmacy, and online outlets. While hemp cultivation is permitted, CBD extraction is prohibited, leading to reliance on imported extracts. Ingestibles remain governed by Novel Food law.

Tolerance: Very High Switzerland maintains one of Europe’s most advanced CBD markets, allowing up to 1% THC in products. CBD items—flowers, vapes, oils, cosmetics—are regulated by product category under the Federal Office of Public Health (FOPH) and Federal Food Safety & Veterinary Office (FSVO). CBD may not be marketed for pharmacological effects, but operates in a fully legal, multi-sector market.

Tolerance: Low The CBD industry remains volatile due to shifting government policy. In April 2025, the government enacted an emergency decree classifying all hemp flower as a narcotic, pending parliamentary approval. If confirmed, this measure could criminalise thousands of businesses. Legal challenges are anticipated at national and EU levels.

Tolerance: Medium Germany’s CBD market remains constrained by the ‘intoxication clause’, which treats low-THC hemp as potentially narcotic. The proposed Industrial Hemp Liberalisation Act (NLG)—intended to remove this clause and permit indoor cultivation and sale of hemp flower—was delayed due to the 2024 snap election. Authorities continue seizures and prosecutions, though farmers’ groups back reform.

Tolerance: Medium CBD cosmetics are legal, but ingestibles are classified as medicines. CBD flower and resin are sold as aromatherapy or collectibles to bypass restrictions.

Tolerance: High The CBD market is well established, bolstered by a January 2025 court ruling clarifying that hemp flower under 0.3% THC is taxable as a tobacco product (34%) and can only be sold in licensed tobacco shops. CBD oils and cosmetics remain widely sold.

Tolerance: Low Only synthetic CBD is approved for use in cosmetics; plant-derived CBD is prohibited. Foods and supplements require Novel Food authorisation.

Tolerance: Medium Following the 2021 Cannabis Reform Act, CBD products—oils, cosmetics, supplements—are widely available. However, CBD flowers remain prohibited, and criminal proceedings have been brought against importers and clinics for sales or purchases.

Tolerance: Very High The Czech Republic leads in CBD and alternative cannabinoid regulation. It allows hemp cultivation up to 1% THC, and the Psychomodulatory Substances Act (effective July 2025) introduces regulated retail for CBD and low-THC products. Retailers must ensure adult-only sales and product-quality verification.

Tolerance: Medium Authorities continue raids on CBD flower retailers amid legal uncertainty. CBD oils remain tolerated, but new laws may classify flower as narcotic.

Tolerance: Low Only synthetic CBD in cosmetics is legal. Plant-derived CBD in food or supplements remains unauthorised under Novel Food rules.

Tolerance: Medium CBD cosmetics are legal, but flowers and oils sold as ‘not for consumption’ remain vulnerable to criminal proceedings. Products must have THC below 0.2%.

Tolerance: Medium CBD products are widely available in retail and specialty stores—flowers, oils, resins, vapes, cosmetics, supplements.

Tolerance: Medium Only THC-free (isolate-based) CBD products are legal. CBD oils, vapes, and cosmetics are available in pharmacies and beauty stores.

Tolerance: Medium CBD derived from industrial hemp (<0.2% THC) is legal if compliant with labelling and quality standards. Food, oil, and cosmetic CBD products are widely distributed.

Tolerance: Medium Authorities tolerate low-THC CBD flower and oil sales. Products are subject to tobacco tax (34%) and may only be sold in licensed outlets, similar to Austria’s framework.

Tolerance: Medium CBD extracts and oils under 0.2% THC are classified as OTC medicines and sold in pharmacies.

Tolerance: Low CBD is classified as a medicinal product requiring marketing authorisation. Raids on unlicensed stores were conducted in January 2025.

Tolerance: Low CBD in food remains Novel Food restricted. Cosmetics exist in a grey zone, with frequent recalls. CBD smoking products may not contain any THC.

Tolerance: Medium Only THC-free CBD cosmetics are permitted officially, but retail stores sell oils, supplements, and flowers informally.

Tolerance: Medium CBD vapes, flowers, and cosmetics are sold, but food supplements require Novel Food approval. E-liquids may contain <0.2% THC under Tobacco Act regulations.

Tolerance: Low CBD ingestibles are banned; only cosmetics and skincare are allowed. CBD in e-liquids is not approved. Customs regularly seizes CBD shipments.

Tolerance: Low Any CBD product containing THC is a narcotic. CBD ingestibles are Novel Food restricted.

Tolerance: Low Naturally derived CBD is classified as a narcotic; only synthetic CBD is permitted for cosmetic use.

Get granular market sizing forecasts, patient population data, and competitive intelligence across 31 European markets. Trusted by investors, operators, and regulators across the continent.